Age-standardized cancer incidence and relative risk of cancer among Métis and non-Aboriginal adults, 1992–2009, by sex* and cancer site, Canada
| Cancer site | No. of cases in Métis† | Ethnic group; ASR‡ per 100 000 | Model no.; RR (95% CI) | ||
|---|---|---|---|---|---|
| Non-Aboriginal | Métis | Model 1§ | Model 2¶ | ||
| All sites | 1090 | 514.3 | 546.4 | 1.06 (1.00–1.12) | 1.05 (0.99–1.11) |
| Men | 570 | 560.7 | 558.2 | 0.99 (0.91–1.07) | 0.97 (0.89–1.06) |
| Women | 525 | 457.4 | 533.0 | 1.14 (1.04–1.24) | 1.13 (1.04–1.24) |
| Lung** | 225 | 73.3 | 114.0 | 1.50 (1.32–1.70) | 1.34 (1.18–1.52) |
| Men | 125 | 89.8 | 125.8 | 1.39 (1.18–1.64) | 1.22 (1.03–1.43) |
| Women | 95 | 57.5 | 107.8 | 1.67 (1.38–2.03) | 1.56 (1.28–1.89) |
| Female breast | 165 | 146.0 | 165.2 | 1.12 (0.97–1.30) | 1.18 (1.02–1.37) |
| Prostate | 145 | 157.3 | 150.2 | 0.96 (0.82–1.11) | 1.00 (0.86–1.17) |
| Colorectal | 115 | 63.9 | 56.4 | 0.90 (0.76–1.08) | 0.90 (0.75–1.06) |
| Men | 75 | 75.4 | 74.3 | 1.02 (0.83–1.26) | 1.03 (0.83–1.26) |
| Women | 35 | 50.3 | 37.0 | 0.71 (0.52–0.97) | 0.69 (0.50–0.95) |
| Non-Hodgkin lymphoma | 40 | 26.1 | 21.0 | 0.85 (0.65–1.12) | 0.86 (0.66–1.13) |
| Kidney | 35 | 13.9 | 17.5 | 1.26 (0.93–1.71) | 1.23 (0.91–1.67) |
| Stomach | 30 | 10.8 | 15.5 | 1.44 (1.04–2.01) | 1.37 (0.98–1.90) |
| Bladder | 30 | 16.9 | 14.1 | 0.80 (0.57–1.11) | 0.79 (0.56–1.10) |
| Oral and pharynx | 25 | 11.9 | 12.9 | 0.98 (0.68–1.41) | 0.88 (0.61–1.27) |
| Pancreas | 25 | 11.6 | 12.2 | 1.04 (0.71–1.53) | 1.03 (0.70–1.51) |
| Uterus | 25 | 28.4 | 25.7 | 0.89 (0.62–1.28) | 0.91 (0.64–1.32) |
| Cervix | 25 | 11.0 | 22.9 | 2.05 (1.37–3.06) | 1.84 (1.23–2.76) |
| Ovary | 25 | 16.5 | 22.6 | 1.38 (0.94–2.03) | 1.41 (0.96–2.08) |
| Liver | 15 | 3.7 | 8.2 | 2.01 (1.25–3.25) | 2.09 (1.30–3.38) |
| Larynx | 15 | 4.2 | 8.1 | 1.82 (1.17–2.83) | 1.60 (1.03–2.48) |
| Thyroid | 15 | 10.3 | 6.6 | 0.69 (0.42–1.13) | 0.76 (0.47–1.24) |
| Melanoma | 10 | 16.8 | 6.5 | 0.49 (0.32–0.76) | 0.54 (0.35–0.84) |
| Brain and CNS | 10 | 8.5 | 4.6 | 0.55 (0.30–1.03) | 0.57 (0.31–1.06) |
| Leukemia | 5 | 7.4 | 3.2 | 0.60 (0.34–0.96) | 0.59 (0.37–0.94) |
| Gallbladder | 5 | 1.3 | 2.8 | 2.50 (1.19–5.27) | 2.35 (1.12–4.96) |
Note: ASR = age-standardized rate, CI = confidence interval, CNS = central nervous system, RR = relative risk.
↵* Breakdown by sex for all sites and the top 4 incident cancer sites (lung, female breast, prostate, colorectal).
↵† According to Statistics Canada protocols, the counts in this table, including totals, are randomly rounded either up or down to a multiple of 5. When data are summed or grouped, the total value may not match the individual values because totals and subtotals are rounded independently.
↵‡ Standardized to the World Standard Population. (23)
↵§ With adjustment for age and sex (if applicable) only.
↵¶ With adjustment for age, sex (if applicable), income and rurality.
↵** Lung cancer = cancers of the lung and bronchus.